AI SummaryTB diagnostic kit manufacturing is a ₹2,500-3,500 crore opportunity in India as of 2026, driven by 27 lakh annual TB cases and urgent need for rapid testing in rural/tribal areas where 50% of delays occur in the first 2 weeks after diagnosis. The government's NTEP program budgets ₹600+ crore annually for diagnostics, and article-cited OpenPCR machines cut testing costs by 80%—making local kit assembly highly competitive. Entrepreneurs with ₹18-25 lakh capital, ICMR certification, and existing clinic/government networks can achieve ₹50-80 lakh monthly revenue within 18 months by securing 1-2 state supply contracts.
Loading...